Log In
BCIQ
Print this Print this
 

COTI-2

  Manage Alerts
Collapse Summary General Information
Company Critical Outcome Technologies Inc.
DescriptionSmall molecule inhibitor of protein kinase B (AKT; AKT1; PKB; PKBA) phosphorylation
Molecular Target Protein kinase B (AKT) (AKT1) (PKB) (PKBA)
Mechanism of ActionProtein kinase B (PKB) (AKT1) inhibitor; p53 activator
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$5.0M

0

0


 Deals Details
Get a free BioCentury trial today